Martek Pursues Direct Consumer Access With Pending Acquisition Of Amerifit
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences' proposed acquisition of Amerifit Brands for $200 million would mark the omega-3 DHA ingredient supplier's first major foray into consumer marketing and would substantially expand the firm's portfolio
You may also be interested in...
Amerifit Shoulders More Responsibility As DSM's "Conduit To The Consumer"
Amerifit Brands launches its first products since Martek Biosciences acquired it, and executives expect continued expansion as DSM integrates the supplement marketer.
Amerifit Shoulders More Responsibility As DSM's "Conduit To The Consumer"
Amerifit Brands launches its first products since Martek Biosciences acquired it, and executives expect continued expansion as DSM integrates the supplement marketer.
Amerifit Shoulders More Responsibility As DSM's "Conduit To The Consumer"
Amerifit Brands launches its first products since Martek Biosciences acquired it, and executives expect continued expansion as DSM integrates the supplement marketer.